1. Home
  2. Analysis
  3. Infection
  4. Omnicef

How effective is Omnicef for Infection? (a real world drug study)

Summary:

Overall ratings: 2.3/5
Long term ratings: 0/5

This is a phase IV clinical study of how effective Omnicef (cefdinir) is for Infection and for what kind of people. The study is created by eHealthMe from 4 Omnicef users and is updated continuously.

What is Omnicef?

Omnicef has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 2,774 Omnicef users. Check the latest studies of Omnicef.

What is Infection?

Infection is found to be associated with 2,503 drugs and 2,590 conditions by eHealthMe. Check the latest studies of Infection.

On Jul, 01, 2026

4 people are studied for taking Omnicef in Infection

Overall effectiveness (number of people):

Does Omnicef work for your Infection (overall)?

Long term (1+ years) effectiveness (number of people):

Does Omnicef work for your Infection (long term)?

Omnicef effectiveness for Infection (number of people):

Overall:
  • not at all: 1
  • somewhat: 1
  • moderate: 2
  • high: 0
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 0
  • high: 0
  • very high: 0

Gender of people who take Omnicef for Infection *:

  • female: 75 %
  • male: 25 %

Age of people who take Omnicef for Infection *:

  • 0-1: 0.0 %
  • 2-9: 25 %
  • 10-19: 0.0 %
  • 20-29: 25 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 25 %
  • 60+: 0.0 %

Who find Omnicef more effective for Infection?

* Approximation only. Some reports may have incomplete information.

Do you take Omnicef?

- You can start a phase IV clinical trial to monitor Omnicef safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on cefdinir (the active ingredients of Omnicef) and Omnicef (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.